← Back to Clinical Trials
Recruiting NCT06490692

NCT06490692 The Effect of Blood Flow Restriction Training on Tennis Elbow

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06490692
Status Recruiting
Phase
Sponsor Cairo University
Condition Tennis Elbow
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2024-06-29
Primary Completion 2024-10-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 28 Years
Study Type INTERVENTIONAL
Interventions
Blood Flow Restriction TrainingConventional Strength Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2024-06-29 with a primary completion date of 2024-10-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled clinical trial is to investigate the effects of blood flow restriction training on the parameters surrounding tennis elbow afflicted patients including pain, disability, and grip strength. The main question this study aims to answer is: 1- Does blood flow restriction training offer significantly better effects on pain, disability, and grip strength when compared to conventional strength training without blood flow restriction in patients afflicted with tennis elbow? Research will compare two groups with tennis elbow where both will perform the same rehabilitation program consisting of conventional physical therapy for tennis elbow as well as a strength training program with the only difference being that one group will undergo blood flow restriction training while the other will not.

Eligibility Criteria

Inclusion Criteria: * Patients that were included in this study were diagnosed with lateral epicondylitis by a medical doctor for less than 3 months. * Dominant hand was diagnosed with lateral epicondylitis. * They were aged between 20 and 40 years old. * With decreased grip strength and wrist range of motion. * No history of physical therapy treatment for lateral epicondylitis for at least 6 months. Exclusion Criteria: * Patients with chronic diabetes. * Any type of trauma or fracture in the upper extremities in the last 3 months. * Patients with any vestibular problems. * Patients with deep vein thrombosis (DVT). * Patients with hypertension. * Patients with cancer.

Frequently Asked Questions

Who can join the NCT06490692 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 28 Years, studying Tennis Elbow. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06490692 currently recruiting?

Yes, NCT06490692 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.

Where is the NCT06490692 trial being conducted?

This trial is being conducted at Beirut, Lebanon.

Who is sponsoring the NCT06490692 clinical trial?

NCT06490692 is sponsored by Cairo University. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology